TNBC constitutes approximately 15% to 20% of all diagnosed breast cancer cases, and is more commonly diagnosed in younger women, African-American women, and those with a breast cancer 1 (BRCA1) gene mutation [32,93,94]. This evidence concerns the gene BRCA1 and breast carcinoma.